EUVIMEDEUVIMED entdecken
Crossref

Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus Vaccines

Jeswin Joseph iD, Kavitha Modenkattil Sethumadhavan iD, Priyanca Ahlawat, Malavika Prakash, Gayatri Kandpal, Gowtham Raj, Harshal Srivastava, Packirisamy Charulekha, Aswin K Dev, Akshaya Radhakrishnan, Virendra Singh, Rahul Yadav und 5 weitere

ACS Nano · 12.08.2025 · 19 (31) · 28295-28314

DOI: 10.1021/acsnano.5c06081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 01.08.2025. Verfasst von Jeswin Joseph und 16 weiteren Autor:innen. Beteiligte Einrichtung: Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananth…. Hauptthemen laut MEDLINE: Nanoparticles, COVID-19 Vaccines, SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 126 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, University Grants Commission, Science and Engineering Research Board.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesCOVID-19 VaccinesSARS-CoV-2COVID-19Multienzyme ComplexesAnimalsMiceSpike Glycoprotein, CoronavirusHumansAntibodies, NeutralizingCross ProtectionFemaleAngiotensin-Converting Enzyme 2Antibodies, Viral

Stichwörter der Autor:innen

coronaviruseslumazine synthasenanoparticle vaccinesprotein nanoparticlesself-assembled nanoparticlesvaccines

Substanzen

6,7-dimethyl-8-ribityllumazine synthaseCOVID-19 VaccinesSpike Glycoprotein, CoronavirusMultienzyme Complexesspike protein, SARS-CoV-2Antibodies, NeutralizingAngiotensin-Converting Enzyme 2Antibodies, Viral

Autor:innen und Institutionen

  • Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram 695551, India.
  • Immuno-biology Laboratory, Translational Health Science & Technology Institute (THSTI), Faridabad 121001, India.
  • School of Chemistry, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram 695551, India.
  • Immuno-biology Lab, Infection and Immunology Centre, Translational Health Science and Technology Institute (THSTI), Faridabad 121001, India.
  • Central Animal Facility, Indian Institute of Science Education and Research Thiruvananthapuram, Thiruvananthapuram 695551, India.

ORCID-Profile: Jeswin Joseph, Kavitha Modenkattil Sethumadhavan, Reji Varghese, V Stalin Raj

Förderung

  • Council of Scientific and Industrial Research, India
  • University Grants Commission
  • Science and Engineering Research Board
  • Department of Science and Technology, Ministry of Science and Technology, India
  • Ministry of Education, India
  • Indian Institute of Science Education and Research Thiruvananthapuram
  • Anusandhan National Research Foundation (ANRF), (ERSTWHILE SERB), New Delhi, India

Zitieren

APA

Joseph, J., Modenkattil Sethumadhavan, K., Ahlawat, P., Prakash, M., Kandpal, G., Raj, G., Srivastava, H., Charulekha, P., K Dev, A., Radhakrishnan, A., Singh, V., Yadav, R., Chandramohanan, P., Varghese, R., Rizvi, Z. A., Awasthi, A., & Raj, V. S. (2025). Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus Vaccines. ACS Nano, 19(31), 28295-28314. https://doi.org/10.1021/acsnano.5c06081

Vancouver

Joseph J, Modenkattil Sethumadhavan K, Ahlawat P, Prakash M, Kandpal G, Raj G, et al. Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus Vaccines. ACS Nano. 2025;19(31):28295-28314. doi:10.1021/acsnano.5c06081

BibTeX
@article{Joseph2025,
  author = {Joseph, Jeswin and Modenkattil Sethumadhavan, Kavitha and Ahlawat, Priyanca and Prakash, Malavika and Kandpal, Gayatri and Raj, Gowtham and Srivastava, Harshal and Charulekha, Packirisamy and K Dev, Aswin and Radhakrishnan, Akshaya and Singh, Virendra and Yadav, Rahul and Chandramohanan, Purnima and Varghese, Reji and Rizvi, Zaigham Abbas and Awasthi, Amit and Raj, V Stalin},
  title = {Lumazine Synthase Nanoparticles as a Versatile Platform for Multivalent Antigen Presentation and Cross-Protective Coronavirus Vaccines},
  journal = {ACS Nano},
  year = {2025},
  volume = {19},
  number = {31},
  pages = {28295--28314},
  doi = {10.1021/acsnano.5c06081}
}
Kostenlos starten →